Hoth Therapeutics Inc (HOTH)

1.07 0.00  0.00% NASDAQ Oct 28, 13:59 USD
View Full Chart
Price Chart
View All HOTH News

News

View All Events

Events

Date Type Description
11/10/2021 Earnings Results Q3 2021 Earnings Results
08/11/2021 Earnings Results Q2 2021 Earnings Results
06/24/2021 12:00 EST AGM 2020 Annual General Meeting
05/13/2021 Earnings Results Q1 2021 Earnings Results
11/10/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
  • URL: https://www.hoththerapeutics.com
  • Investor Relations URL: N/A
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 10, 2021
  • Last Earnings Release: Aug. 11, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.